Home › Funds › PFM Health Sciences, LP › COO
PFM Health Sciences, LP position in COO
COOPER COS INC · Health Care
PFM Health Sciences, LP reported holding 220,890 shares of COO (COOPER COS INC) in its Q2 2026 13F filing — a position valued at US$15.8M, representing 1.39% of its reported portfolio and ranking #23 among its reported holdings. PFM Health Sciences, LP has disclosed COO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's COO position evolved
PFM Health Sciences, LP first disclosed a stake in COO in Q3 2025 at 74,363 shares (US$5.1M). The position peaked in Q2 2026 at 220,890 shares, worth US$15.8M. Across 4 filings, PFM Health Sciences, LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 220,890 shares valued at US$15.8M — an increase of 51,061 shares quarter over quarter.. Notable position changes include a 36% increase in Q4 2025 (shares fell 13% over the following quarter), a 68% increase in Q1 2026 (shares were roughly flat over the following quarter), a 30% increase in Q2 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 74.36K | $5.10M | New |
| Q4 2025 | 100.80K | $8.26M | Add |
| Q1 2026 | 169.83K | $12.14M | Add |
| Q2 2026 | 220.89K | $15.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COO and 13F data
COO (COOPER COS INC) is a Health Care company. 28 other funds we track also report a position in COO — the largest reported positions include BROWNING WEST LP (US$516.0M), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$389.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$356.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COO
- BROWNING WEST LP 7.20M sh · $515.98M · Q2 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 5.43M sh · $389.41M · Q2 2026
- GENERATION INVESTMENT MANAGEMENT LLP 4.97M sh · $356.30M · Q2 2026
- Longview Partners (Guernsey) LTD 3.94M sh · $282.54M · Q2 2026
- JANA Partners Management, LP 3.58M sh · $256.90M · Q2 2026
- LONDON CO OF VIRGINIA 2.90M sh · $207.82M · Q2 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 2.73M sh · $195.85M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held COO?
PFM Health Sciences, LP has disclosed COO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is PFM Health Sciences, LP's current position in COO?
As of Q2 2026, PFM Health Sciences, LP holds 220.89K shares of COO (COOPER COS INC), valued at $15.84M, representing 1.39% of its reported portfolio and ranking #23.
Has PFM Health Sciences, LP been buying or selling COO?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in COO. The position peaked in Q2 2026 at 220.89K shares.
Which other funds hold COO?
Other major institutional holders of COO include BROWNING WEST LP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, GENERATION INVESTMENT MANAGEMENT LLP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.